Literature DB >> 12871208

Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization.

Su Duy Nguyen1, Dai-Eun Sok.   

Abstract

The effect of lipids on PON1 (paraoxonase 1), one of antioxidant proteins in high-density lipoprotein, was investigated in respect to inhibition, protection against oxidative inactivation, and stabilization. When the effect of lipids on the PON1 activity was examined, a remarkable inhibition was expressed by polyenoic fatty acids (C18:2-C20:5). Linoleic acid, the most potent ( K(i), 3.8 microM), showed competitive inhibition. Next, various lipids were examined for prevention against the inactivation of PON1 by ascorbate/Cu2+, which caused a remarkable (>or =90%) inactivation of PON1. Compared with saturated fatty acids (C6-C18), exhibiting a modest protection (9-40%), monoenoic acids (C16:1-C20:1) showed a greater maximal protective effect (Emax, 70-82%), with oleic acid being the most effective (EC50, 2.7 microM). In contrast, polyenoic acids showed no protection. Noteworthy, linoleic acid prohibited the protective action of oleic acid non-competitively. In the structure-activity relationship, a negatively charged group seems to be required for the protective action. Consistent with this, dioleoylphosphatidylglycerol, negatively charged, was more protective than dioleoylphosphatidylcholine. These data, together with requirement of Ca2+ (EC50, 0.6 microM) for the protective action, may support the existence of a specific site responsible for the protective action. A similar protective action of lipids was also observed in the inactivation of PON1 by ascorbate/Fe2+, peroxides or p -hydroxymercuribenzoate. Separately, PON1 was stabilized by oleic acid or oleoylated phospholipids, in combination with Ca2+, but not linoleic acid. These results suggest that in contrast to an adverse action of linoleic acid, monoenoic acids or their phospholipid derivatives play a beneficial role in protecting PON1 from oxidative inactivation as well as in stabilizing PON1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871208      PMCID: PMC1223694          DOI: 10.1042/BJ20030663

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

1.  Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.

Authors:  Z Ahmed; A Ravandi; G F Maguire; A Emili; D Draganov; B N La Du; A Kuksis; P W Connelly
Journal:  J Biol Chem       Date:  2001-04-24       Impact factor: 5.157

2.  Evidence that several conserved histidine residues are required for hydrolytic activity of human paraoxonase/arylesterase.

Authors:  J A Doorn; R C Sorenson; S S Billecke; C Hsu; B N La Du
Journal:  Chem Biol Interact       Date:  1999-05-14       Impact factor: 5.192

3.  Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities.

Authors:  D Josse; W Xie; F Renault; D Rochu; L M Schopfer; P Masson; O Lockridge
Journal:  Biochemistry       Date:  1999-03-02       Impact factor: 3.162

4.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

5.  Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.

Authors:  R C Sorenson; C L Bisgaier; M Aviram; C Hsu; S Billecke; B N La Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

6.  Dietary fat modulates serum paraoxonase 1 activity in rats.

Authors:  B J Kudchodkar; A G Lacko; L Dory; T V Fungwe
Journal:  J Nutr       Date:  2000-10       Impact factor: 4.798

7.  Decreased aortic early atherosclerosis in hypercholesterolemic hamsters fed oleic acid-rich TriSun oil compared to linoleic acid-rich sunflower oil.

Authors:  Robert J. Nicolosi; Thomas A. Wilson; Garry Handelman; Thomas Foxall; John F. Keaney; Joseph A. Vita
Journal:  J Nutr Biochem       Date:  2002-07       Impact factor: 6.048

8.  Effects of specific fatty acids (8:0, 14:0, cis-18:1, trans-18:1) on plasma lipoproteins, early atherogenic potential, and LDL oxidative properties in the hamster.

Authors:  R J Nicolosi; T A Wilson; E J Rogers; D Kritchevsky
Journal:  J Lipid Res       Date:  1998-10       Impact factor: 5.922

Review 9.  Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

Authors:  J A Berliner; M Navab; A M Fogelman; J S Frank; L L Demer; P A Edwards; A D Watson; A J Lusis
Journal:  Circulation       Date:  1995-05-01       Impact factor: 29.690

10.  PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity.

Authors:  Leila Jaouad; Christelle Milochevitch; Abdelouahed Khalil
Journal:  Free Radic Res       Date:  2003-01
View more
  9 in total

1.  Paraoxonase 1 activity in chylomicrons and VLDL: the effect of type 2 diabetes and meals rich in saturated fat and oleic acid.

Authors:  Patrick J Manning; Sylvia A de Jong; Anne R Ryalls; Wayne H F Sutherland
Journal:  Lipids       Date:  2011-12-10       Impact factor: 1.880

Review 2.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

Review 3.  Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

Authors:  Lucio G Costa; Gennaro Giordano; Clement E Furlong
Journal:  Biochem Pharmacol       Date:  2010-11-18       Impact factor: 5.858

Review 4.  Paraoxonases: metabolic role and pharmacological projection.

Authors:  Carlos Moya; Salvador Máñez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

5.  Differential effect of lysophospholipids on activities of human plasma paraoxonase1, either soluble or lipid-bound.

Authors:  Cheon Ho Park; Su Duy Nguyen; Mee Ree Kim; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2006-04       Impact factor: 1.880

6.  Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved.

Authors:  Elena Thomàs-Moyà; Magdalena Gianotti; Ana M Proenza; Isabel Lladó
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

7.  Dietary fatty acid intake is associated with paraoxonase 1 activity in a cohort-based analysis of 1,548 subjects.

Authors:  Daniel Seung Kim; Sean K Maden; Amber A Burt; Jane E Ranchalis; Clement E Furlong; Gail P Jarvik
Journal:  Lipids Health Dis       Date:  2013-12-12       Impact factor: 3.876

Review 8.  Dietary marine-derived long-chain monounsaturated fatty acids and cardiovascular disease risk: a mini review.

Authors:  Zhi-Hong Yang; Beatrice Emma-Okon; Alan T Remaley
Journal:  Lipids Health Dis       Date:  2016-11-22       Impact factor: 3.876

9.  Serum paraoxonase 1 activity is associated with fatty acid composition of high density lipoprotein.

Authors:  Maryam Boshtam; Amirnader Emami Razavi; Morteza Pourfarzam; Mohsen Ani; Gholam Ali Naderi; Gholam Basati; Marjan Mansourian; Narges Jafari Dinani; Seddigheh Asgary; Soheila Abdi
Journal:  Dis Markers       Date:  2013-09-12       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.